Concussion drug therapies on the horizon
Drug Discovery World
APRIL 23, 2024
Although not a test to diagnose concussion, a biomarker test developed by Abbott Laboratories helps to determine whether a patient should receive a CT scan to rule out haemorrhage. Tremendous strides have been made with other diseases, yet there are still no FDA-approved drug therapies for TBI.
Let's personalize your content